Literature DB >> 4106226

Phentolamine for vasodilator treatment of severe heart-failure.

P A Majid, B Sharma, S H Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4106226     DOI: 10.1016/s0140-6736(71)92098-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  42 in total

Review 1.  Manipulating afterload for the treatment of acute heart failure. A historical summary.

Authors:  Claude Perret; Jean-François Enrico
Journal:  Intensive Care Med       Date:  2003-01-30       Impact factor: 17.440

2.  Afterload reduction in the therapy of heart failure.

Authors:  W H Fennell
Journal:  Tex Heart Inst J       Date:  1982-03

3.  Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study.

Authors:  C l Perret; J P Gardaz; M Reynaert; F Grimbert; J F Enrico
Journal:  Br Heart J       Date:  1975-06

Review 4.  Vascular tone in heart failure: the neuroendocrine-therapeutic interface.

Authors:  J G Cleland; C M Oakley
Journal:  Br Heart J       Date:  1991-10

5.  [Hemodynamic interferences between diltiazem and thiopental--experimental study in the pig].

Authors:  M Pierrot; M Blaise; S Hugon; F Bonnel; M Cupa
Journal:  Can Anaesth Soc J       Date:  1984-03

6.  Cardiogenic shock. Current concepts in management.

Authors:  K Balakumaran; P G Hugenholtz
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

7.  Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.

Authors:  J Mehta; M Iacona; C J Pepine; C R Conti
Journal:  Br Heart J       Date:  1979-12

8.  Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.

Authors:  K Chatterjee; T A Ports; S Arnold; B Brundage; W Parmley
Journal:  Br Heart J       Date:  1979-12

9.  Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.

Authors:  P W Armstrong
Journal:  Can Med Assoc J       Date:  1979-10-06       Impact factor: 8.262

10.  Treatment of chronic heart failure with slow release phentolamine.

Authors:  A J Georgopoulos; A Valasidis; D Siourthas
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.